Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Guern

Showing results (411-420 of 423) with videos related to

Pageof 43
Sort By:
Arthritis Research & Therapy|September 26, 2020
Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherenceBenoit Blanchet, Moez Jallouli, Marie Allard, et al.
Annals of the Rheumatic Diseases|December 7, 2014
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Raphaèle Seror, Hendrika Bootsma, Alain Saraux, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Annals of the Rheumatic Diseases|November 19, 2020
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trialRenaud Felten, Valérie Devauchelle-Pensec, Raphaèle Seror, et al.
The Lancet. Rheumatology|January 23, 2024
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, Gaëlle Guettrot-Imbert, Véronique Le Guern, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 17, 2023
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception CohortYann Nguyen, Benoît Blanchet, Murray B Urowitz, et al.
The Lancet. Rheumatology|January 22, 2024
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyGrégoire Martin de Frémont, Nathalie Costedoat-Chalumeau, Estibaliz Lazaro, et al.
La Revue De Medecine Interne|February 23, 2016
[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]A Mathian, L Arnaud, D Adoue, et al.
Brain : a Journal of Neurology|October 23, 2021
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degenerationMathieu Barbier, Agnès Camuzat, Khalid El Hachimi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug MonitoringShivani Garg, Benoît Blanchet, Yann Nguyen, et al.
Pageof 43

Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
Arthritis Research & Therapy|September 26, 2020
Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherenceBenoit Blanchet, Moez Jallouli, Marie Allard, et al.
Annals of the Rheumatic Diseases|December 7, 2014
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Raphaèle Seror, Hendrika Bootsma, Alain Saraux, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Annals of the Rheumatic Diseases|November 19, 2020
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trialRenaud Felten, Valérie Devauchelle-Pensec, Raphaèle Seror, et al.
The Lancet. Rheumatology|January 23, 2024
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, Gaëlle Guettrot-Imbert, Véronique Le Guern, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 17, 2023
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception CohortYann Nguyen, Benoît Blanchet, Murray B Urowitz, et al.
The Lancet. Rheumatology|January 22, 2024
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyGrégoire Martin de Frémont, Nathalie Costedoat-Chalumeau, Estibaliz Lazaro, et al.
La Revue De Medecine Interne|February 23, 2016
[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]A Mathian, L Arnaud, D Adoue, et al.
Brain : a Journal of Neurology|October 23, 2021
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degenerationMathieu Barbier, Agnès Camuzat, Khalid El Hachimi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug MonitoringShivani Garg, Benoît Blanchet, Yann Nguyen, et al.
Pageof 43